TD Asset Management
ANRO icon

TD Asset Management’s Alto Neuroscience ANRO Stock Holding History

TD Asset Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$985K Buy
+43,800
New +$812K ﹤0.01% 1093
2025
Q1 		– Sell
-110,792
Closed -$469K – 1282
2024
Q4 		$469K Buy
110,792
+33,800
+44% +$211K ﹤0.01% 1191
2024
Q3 		$932K Sell
76,992
-9,800
-11% -$120K ﹤0.01% 1201
2024
Q2 		$928K Buy
+86,792
New +$1.13M ﹤0.01% 1174

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TD Asset Management's ANRO Position: Q1 2026 in Review

TD Asset Management opened a new position in Alto Neuroscience (ANRO) in Q1 2026: 43,800 shares worth $985K. The stake represents ﹤0.01% of the portfolio and ranks #1093 among its holdings. This is a return to the name: TD Asset Management previously reported a position in ANRO as recently as Q4 2024.

TD Asset Management first reported a position in ANRO in Q2 2024 and has held it in 4 quarters since. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • TD Asset Management held 43,800 shares of Alto Neuroscience worth $985K as of Q1 2026.
  • Alto Neuroscience was a new TD Asset Management position in Q1 2026.
  • Alto Neuroscience made up ﹤0.01% of TD Asset Management's portfolio in Q1 2026, its #1093 holding.
  • TD Asset Management first reported a position in Alto Neuroscience in Q2 2024 and has held it in 4 quarters since.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.